Companies · Other Health Care

Squareone, Inc.

MOUNTAIN VIEW · Other Health Care

Diligence memoA one-page analyst read on Squareone, Inc. — recommendation, valuation, rhythm, risks.
$15.9M
Total raised · real
5
Rounds
0.8×
Latest step-up
Top 19%
Sector rank · raised
Series A
Latest stage · inferred · Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)

Squareone, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.65× the median modeled value of Series A Other Health Care companies in 2007–2009 (48 peers) — value vs value, same stage and era.
Dormant
  • Last raise 17.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Squareone, Inc. is one of 5376 Other Health Care companies tracked from MOUNTAIN VIEW. By capital raised it ranks in the upper tier (ahead of 82% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · 2009-03-24 Raised $4.0M (real) Modeled valuation $82M (est)$4.0M$82MSeries A2009Seed · 2009-03-24 Raised $3.4M (real) Modeled valuation $85M (est)$3.4M$85MSeed2009Seed · 2009-03-24 Raised $3.4M (real) Modeled valuation $84M (est)$3.4M$84MSeed2009Seed · 2009-03-24 Raised $2.8M (real) Modeled valuation $70M (est)$2.8M$70MSeed2009Seed · 2009-03-24 Raised $2.3M (real) Modeled valuation $56M (est)$2.3M$56MSeed2009+$3.4M+$3.4M+$2.8M+$2.3MCumulative $16M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$4.0M · 2009
Bridge · Series A-stage$3.4M · 2009smaller follow-on
Bridge · Series A-stage$3.4M · 2009smaller follow-on
Bridge · Series A-stage$2.8M · 2009smaller follow-on
Bridge · Series A-stage$2.3M · 2009smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$81.5M
Base estimate est.
$5.2M
Conservative case
$443.3M
Upside case
$18.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $81.5M · 2009-03-242009Seed · modeled $85.0M · 2009-03-24Seed · modeled $84.1M · 2009-03-24Seed · modeled $69.8M · 2009-03-24Seed · modeled $55.8M · 2009-03-242009
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
17.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
17.3 yr
On record since
2009
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.6× above median
This company$15.9M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.4× of median
This company$2.3M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 3.7× above median
This company$81.5M
Sector median$22.1M

Raised more than 82% of sector peers (real $). Modeled value above 75% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #46 of 48.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Dynova Laboratories Inc · Series A Raised $26.0M · modeled $302.7M (est)Vocollect Inc · Series A Raised $15.0M · modeled $302.7M (est)Salient Surgical Technologies, Inc. · Series A Raised $18.4M · modeled $302.7M (est)Orthohelix Surgical Design Inc · Series A Raised $23.4M · modeled $283.2M (est)CardioPolymers, Inc. · Series A Raised $13.6M · modeled $273.9M (est)Natural Dentist Inc · Series A Raised $12.6M · modeled $255.1M (est)Granite Investment Group · Series A Raised $12.5M · modeled $252.2M (est)Portaero, Inc · Series A Raised $11.8M · modeled $238.5M (est)Prematics Inc · Series A Raised $10.8M · modeled $217.7M (est)Replenish, Inc. · Series A Raised $10.2M · modeled $206.8M (est)Wellsense Technologies LLC · Series A Raised $9.2M · modeled $185.0M (est)Docusys Inc · Series A Raised $8.8M · modeled $178.4M (est)Squareone, Inc. (this company) Raised $15.9M · modeled $81.5M (est)Squareone, Inc.
CompanyStageRaised · realValue · estvs peer med.
Dynova Laboratories IncSeries A$26.0M$302.7M2.42×
Vocollect IncSeries A$15.0M$302.7M2.42×
Salient Surgical Technologies, Inc.Series A$18.4M$302.7M2.42×
Orthohelix Surgical Design IncSeries A$23.4M$283.2M2.26×
CardioPolymers, Inc.Series A$13.6M$273.9M2.19×
Natural Dentist IncSeries A$12.6M$255.1M2.04×
Granite Investment GroupSeries A$12.5M$252.2M2.02×
Portaero, IncSeries A$11.8M$238.5M1.91×
Prematics IncSeries A$10.8M$217.7M1.74×
Replenish, Inc.Series A$10.2M$206.8M1.65×
Wellsense Technologies LLCSeries A$9.2M$185.0M1.48×
Docusys IncSeries A$8.8M$178.4M1.43×
Squareone, Inc. this companySeries A$15.9M$81.5M0.65×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$4.0M2009-03-24$18.4M$81.5M90%
Seed$3.4M2009-03-24$17.1M$85.0M90%
Seed$3.4M2009-03-24$17.0M$84.1M90%
Seed$2.8M2009-03-24$14.1M$69.8M90%
Seed$2.3M2009-03-24$11.3M$55.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$4.0M2009-03-24
    • First recorded raise — entered as Series A.
  2. Seed$3.4M2009-03-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  3. Seed$3.4M2009-03-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Seed$2.8M2009-03-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  5. Seed$2.3M2009-03-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
Intelligence
Modeled next raise
$2.3M
Modeled next size est.range $2.3M$3.6M
0.8×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
FARHAD KHOSRAVI13 other2009-03
Mark Wan9 other2009-03
Amar Sawhney5 other2009-03
Rob Kuhling2 other2009-03
Suresh Pai2 other2009-03
Louis Soto1 other2009-03
James Dreher2009-03
Jonathan Bohane2009-03
Registry & provenance

Squareone, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1340477
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Access Closure, Inc.OtherSeries A$23.6M$15.6Mnetwork4 shared operators · same stage
Hotspur Technologies IncOther Health CareSeed$20.6M$91.2Mnetwork3 shared operators · same sector
Trireme Medical IncOther Health CareSeries A$14.7M$153.4Mnetwork1 shared operator · same sector · same stage
Tulavi Therapeutics, Inc.BiotechnologySeries A$14.5M$17.9Mnetwork2 shared operators · same stage
Apama Medical, Inc.HealthtechSeries A$14.3M$297.4Mnetwork2 shared operators · same stage
Soteira, Inc.Other Health CareSeries A$10.9M$7.6Mnetwork1 shared operator · same sector · same stage
Ostial CorpOther Health CareSeries A$10.4M$71.6Mnetwork1 shared operator · same sector · same stage
Endochoice, Inc.Other Health CareSeries A$15.4M$90.6Msame sector · same stage
Frequently asked
How much funding has Squareone, Inc. raised?
Squareone, Inc. has raised approximately $15.9M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Squareone, Inc.'s estimated valuation?
Provath's modeled valuation for Squareone, Inc. is approximately $81.5M (modeled range $5.2M–$443.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Squareone, Inc. at?
Squareone, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Mar 24.
What does Squareone, Inc. do and where is it based?
Squareone, Inc. operates in the Other Health Care sector, based in MOUNTAIN VIEW.
Explore related

See where Squareone, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Squareone, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.